Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
45,922,263
-
Share change
-
+13,865,412
-
Total reported value
-
$132,256,731
-
Price per share
-
$2.88
-
Number of holders
-
41
-
Value change
-
+$39,920,634
-
Number of buys
-
25
-
Number of sells
-
17
Institutional Holders of GRACELL BIOTECHNOLOGIES INC - SPONSORED ADS (GRCL) as of Q3 2023
As of 30 Sep 2023,
GRACELL BIOTECHNOLOGIES INC - SPONSORED ADS (GRCL) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,922,263 shares.
The largest 10 holders included
Vivo Capital, LLC, Temasek Holdings (Private) Ltd, ORBIMED ADVISORS LLC, TCG Crossover Management, LLC, Logos Global Management LP, Sio Capital Management, LLC, SPHERA FUNDS MANAGEMENT LTD., Pivotal bioVenture Partners Investment Advisor LLC, BAKER BROS. ADVISORS LP, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
41
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.